The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 405.50
Bid: 402.50
Ask: 415.50
Change: -2.00 (-0.49%)
Spread: 13.00 (3.23%)
Open: 408.50
High: 411.00
Low: 405.50
Prev. Close: 407.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Santander AT1 Pre-Stabilisation Notice

26 Sep 2017 08:49

RNS Number : 8130R
Barclays Bank PLC
26 September 2017
 

pre-stabilisation announcement

26 September 2017

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Banco Santander, S.A.

Stabilisation Notice

 

Barclays Bank PLC (debt syndicate desk; telephone: +44 20 7773 9098) hereby gives notice that the Stabilising Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU 1052/2016 under the Market Abuse Regulation (EU/596/2014).

 

The securities:

Issuer:

Banco Santander, S.A.

Guarantor (if any):

N/A

Aggregate nominal amount:

EUR TBA

Description:

Non-Step Up Non-Cumulative Contingent Convertible Perpetual Preferred Tier 1 Securities

Offer price:

 TBA

Stabilisation:

Stabilisation Manager:

Barclays Bank PLC

 

Stabilisation period expected to start on:

26 September 2017

Stabilisation period expected to end no later than:

25 October 2017

Existence, maximum size and conditions of use of over-allotment facility.

Barclays Bank PLC (or any person acting on behalf of the Stabilising Manager) may over‑allot Preferred Securities or effect transactions with a view to supporting the price of the Preferred Securities at a level higher than that which might otherwise prevail. Any stabilisation action or over‑allotment must be conducted in accordance with all applicable laws and rules.

 

In connection with the offer of the above securities, the Stabilising Manager (or any person acting on behalf of the Stabilising Manager) may over-allot the securities or effect transactions with a view to supporting the price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted by the Stabilisation Manager (or any person acting on behalf of the Stabilising Manager) in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom and is not intended to be an invitation or inducement to engage in investment activity for the purpose of Section 21 of the Financial Services and Markets Act 2000 of the United Kingdom (the "FSMA"). This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) of the United Kingdom (the "Order"), high net worth entities falling within Article 49(2)(a) to (d) of the Order or any other persons to whom this announcement for the purposes of Section 21 of the FSMA can otherwise lawfully be distributed (all such persons together being referred to as "relevant persons"), and must not be acted on or relied upon by persons other than relevant persons. Any investment or investment activity to which this announcement relates is available only to and will be engaged in only with relevant persons.

 

The securities to which this announcement relates are not intended to be sold and should not be sold to retail clients in the EEA, as defined in the rules set out in the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015, as amended or replaced from time to time, other than in circumstances that do not and will not give rise to a contravention of those rules by any person.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an exemption from registration under such Act. There will be no public offer of securities in the United States or in any other jurisdiction.

 

The securities to which this announcement relates must not be offered, distributed or sold neither in Spain nor to Spanish residents. No publicity of any kind shall be made in Spain.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STADQLBLDKFZBBE
Date   Source Headline
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.